Treatment with Liyuan Pure Lysothrombusase(办源精纯溶栓酶) for 60 cases with unstable angina pectoris

VernacularTitle:力源精纯溶栓酶治疗冠心病不稳定型心绞痛60例
Author: Jianshe LU ; Chunxia YANG
Publication Type:Journal Article
From: Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2001;8(1):18-20
CountryChina
Language:Chinese
Abstract: Objective:To investigate the clinically curative effects of Liyuan Pure Lysothrombusase(LYPL，力源精纯溶栓酶) on unstable angina pectoris (UAP) and to observe its safety.Methods:One hundred and twenty cases with UAP were selected and in accordance with the proportion of one to one randomly divided into treated and control group.Based on conventional therapy the LYPL infused intravenously was added in treated group.The conditions of symptomatic convalescence,the changes in electrocardiography (ECG),and the parameters of blood rheology were observed for two groups.Results:The curative effects on symptoms and ECG were 93.33％ and 88.33％ respectively in treated group but in control group they were 70.00％ and 68.33％ respectively.The difference in comparison between two groups was significant (all P<0.01).In treated group the parameters of blood rheology were obviously improved meanwhile in control group they were not.Conclusions:LYPL possesses the actions on improving blood rheology.Its curative effects on UAP are marked and it is safe and easy to use.